期刊文献+

骨成形蛋白7拮抗转化生长因子β1致肾小管上皮细胞细胞外基质分泌的作用 被引量:2

Antagonistic effect of bone morphogenetic protein-7 on transforming growth factor-β1 induced extracellular matrix synthesis
下载PDF
导出
摘要 目的:观察骨成形蛋白7(BMP-7)拮抗转化生长因子β1(TGF-β1)诱导人肾小管上皮细胞(HK-2)细胞外基质(ECM)分泌作用,并对相关信号通路进行研究,对BMP-7抗纤维化机制进行深入探讨。方法:将不同浓度BMP-7预处理HK-2细胞,随后予以5ng/mlTGF-β1刺激,利用荧光实时定量PCR和Western印迹检测ECM表达、利用Western印迹和凝胶迁移滞后实验(EMSA)检测相关信号通路蛋白表达。结果:荧光实时定量PCR和Western印迹结果表明,BMP-7可以浓度依赖方式下调TGF-β1刺激后HK-2细胞I型胶原,III型胶原,纤维连接蛋白在mRNA和蛋白水平表达。TGF-β1可促进HK-2细胞Smad2、Smad3磷酸化。但TGF-β1上调的Smad2、Smad3磷酸化可被BMP-7抑制,差异有统计学意义(P<0.05和P<0.01)。EMSA结果表明,BMP-7则可抑制TGF-β1上调的NF-κB活性。结论:BMP-7可通过抑制Smad2/3磷酸化、抑制NF-κB的DNA结合活性达到阻断TGF-β1诱导HK-2分泌ECM的效应。 Objective:To investigate the molecular details in antifibrotic effects of bone morphogenetic protein-7 (BMP-7) on TGF-β1 induced extra-cellular matrix (ECM) production. Methodology:In human proximal tubular cells (HK-2), the expressions of fibronectin, collagen type Ⅲ and collagen type Ⅰ were measured by real-time PCR and western blot. The expressions of Smads were examined by Western blot and NK-B activity was detected by electrophoretic mobility shift assay (EMSA). Results:BMP-7 could antagonized TGF-β1 induced collagen type Ⅰ, collagen type Ⅲ and fibronectin mRNA and protein expression in a dose-dependent manner. The application of BMP-7 in the presence of TGF-β1 resulted in reduced Smad 2/3 phosphorylation. BMP-7 could also significantly down-regulated TGF-β1 induced NF-κB activity. Conclusion:BMP-7 could counteract TGF-β1 induced fibrogenesis. The inhibitory effects of BMP-7 on TGF-β1 induced ECM production could be mediated by inhibiting Smad 2/3 phosphorylation and NF-κB activity.
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 2008年第6期529-533,共5页 Chinese Journal of Nephrology,Dialysis & Transplantation
基金 国家自然科学基金(30600291) 上海市重点学科(T0201) 上海市卫生局重点课题(2003ZD002) 上海市卫生局重点学科基金(05Ⅲ001)
关键词 转化生长因子Β 骨成形蛋白7 细胞外基质 人肾小管上皮细胞 bone morphogenetic protein-7 transforming growth factor β1 extra-cellular matrix human proximal tubular cells
  • 相关文献

参考文献19

  • 1Khwaja A, E1 Kossi M, Floege J, et al. The management of CKD : A look into the future. Kidney Int, 2007,72 : 1316 - 1323.
  • 2Liu Y. Renal fibrosis: New insights into the pathogenesis and therapeutics. Kidney Int, 2006,69:213 - 217.
  • 3Zeisberg M, Hanai J, Sugimoto H, et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med, 2003,9:964 - 968.
  • 4Baricos WH, Cortez SL, Deboisblanc M, et al. Transforming growth factor-beta is a potent inhibitor of extracellular matrix degradation by cultured human mesangial cells. J Am Soc Nephrol, 1999,10:790 - 795.
  • 5Dudley AT, Lyons KM, Robertson EJ. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev, 1995,9:2795 - 2807.
  • 6Luo G, Hofmann C, Bronckers AL, et al. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev, 1995,9:2808 - 2820.
  • 7De Petris L, Hruska KA, Chieehio S, et al. Bone morphogenetie protein-7 delays podocyte injury due to high glucose. Nephrol Dial Transplant, 2007,22:3442 - 3450.
  • 8Mitu GM, Wang S, Hirschberg R. BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury. Am J Physiol Renal Physiol, 2007,293 : F1641 - 1648.
  • 9Wang S, de Caestecker M, Kopp J, et al. Renal bone morphogenetic protein-7 protects against diabetic nephropathy. J Am Soc Nephrol, 2006,17:2504 -2512.
  • 10Derynck R, Zhang Y, Feng XH. Smads: Transcriptional activators of TGF-beta responses. Cell, 1998,95:737 -740.

二级参考文献14

  • 1Border WA, Noble NA. TGF-beta in kidney fibrosis: A target for gene therapy. Kidney Int, 1997, 51: 1388-1397.
  • 2Riser BL, Denichilo M, Cortes P, et al. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol, 2000, 11: 25-38.
  • 3Heusinger RJ, Eberlein M, Wahab NA, et al. Expression of connective tissue growth factor in human renal fibroblasts: regulatory roles of RhoA and camp.J Am Soc Nephrol, 2001, 12: 1853-1861.
  • 4Gupta S, Clarkson MR, Duggan J. Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int, 2000, 58: 1389-1399.
  • 5Ito Y, Aten J, Bende RJ, et al. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int, 1998, 53: 853-861.
  • 6Zhang SY, Suzuki D, Umezono T, et al. Expression of connective tissue growth factor mRNA in human IgA nephropathy. Clin Exp Nephrol, 2001, 5: 33-39.
  • 7Abbate M, Zoja C, Rottoli D, et al. Proximal tubular cells promote fibrogenesis by TGF-β1-mediated induction of peritubular myofibroblasts. Kidney Int, 2002, 62: 2066-2077.
  • 8Fine LG, Norman JT, Ong A.Cell-cell cross-talk in the pathogenesis of renal interstitial fibrosis. Kidney Int, 1995,47 ( Suppl 49): S48-S50.
  • 9Grotendorst GR, Okochi H, Hayashi N. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ,1996, 7: 469-480.
  • 10黄海长,李惊子,王海燕.结缔组织生长因子诱导肾成纤维细胞转为成肌纤维细胞[J].科学通报,2002,47(1):37-40. 被引量:65

共引文献22

同被引文献10

引证文献2

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部